Your Article Summary
See Latest ArticlesRegression of Vasoproliferative Tumor With Systemic Infliximab
Ophthalmic Surgery, Lasers and Imaging, 07/25/08
Japiassu RM et al. - The patient underwent treatment with infliximab intravenously for his systemic condition. Regression of the vasoproliferative tumors in both eyes and improvement of macular edema in the left eye was observed. Although the data are limited, anti-TNF antibodies such as infliximab may be useful in the treatment of retinal vascular tumors.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of oral azithromycin in the treatment of chlamydial conjunctivitis
Eye, 11/09/09
Central Corneal Thickness During Treatment With Travoprost 0.004% in Glaucoma Patients
Journal of Ocular Pharmacology and Therapeutics, 11/02/09
Retinal function in patients treated with tamoxifen
Documenta Ophthalmologica, 11/16/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Primary extranodal marginal zone lymphoma of the uvea associated with massive diffuse epibulbar extension and focal infiltration of the optic nerve and meninges, clinically presented as uveitis masquerade syndrome: a case report
Medical Oncology, 10/16/09
Intravascular presence of tumor cells as prognostic parameter in uveal melanoma: a 35-year survey
Investigative Ophthalmology and Visual Science, 10/15/09
Depression and quality of life during treatment of ocular bulb removal in individuals with uveal melanoma
European Journal of Cancer Care, 11/18/09
Today in Retina...keeping you current
Receive free subspecialty "5-minute updates" via email
Value of retinal examination in hypertensive encephalopathy
Journal of Human Hypertension, 11/03/09
Retinopathy of Prematurity
NeoReviews, 11/04/09
Retinal function in patients treated with tamoxifen
Documenta Ophthalmologica, 11/16/09